Varaico: Literature-Extracted Genetic Variants

Gene:DNM2
Variant:p.V625del1
Back to variants list

DNM2

NM_001005361.3:p.V625del1

Associated Papers

A novel DNM2 variant associated with centronuclear myopathy: a case report.

Rimoldi M et al.

Frontiers in Genetics, 2025

40259930 (PubMed )
Supplement: DataSheet1.pdf

[The dynamin-2-gene related centronuclear myopathy].

Bitoun M

Medecine Sciences : M/s, 2023

Dynamin 2 (DNM2) as Cause of, and Modifier for, Human Neuromuscular Disease.

Zhao M et al.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics, 2018

Impaired dynamin 2 function leads to increased AP-1 transcriptional activity through the JNK/c-Jun pathway.

Szymanska E et al.

Cellular Signalling, 2016

A mutation associated with centronuclear myopathy enhances the size and stability of dynamin 2 complexes in cells.

James NG et al.

Biochimica Et Biophysica Acta, 2014

Dynamin-2 in nervous system disorders.

González-Jamett AM et al.

Journal of Neurochemistry, 2014

Dynamin-2 function and dysfunction along the secretory pathway.

González-Jamett AM et al.

Frontiers in Endocrinology, 2013

Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.

Gibbs EM et al.

Journal of Molecular Medicine (berlin, Germany), 2013

A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy.

Kierdaszuk B et al.

Neuromuscular Disorders : Nmd, 2013

Mutation spectrum in the large GTPase dynamin 2, and genotype-phenotype correlation in autosomal dominant centronuclear myopathy.

Böhm J et al.

Human Mutation, 2012

Dynamin GTPase regulation is altered by PH domain mutations found in centronuclear myopathy patients.

Kenniston JA et al.

The Embo Journal, 2010

Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.

Susman RD et al.

Neuromuscular Disorders : Nmd, 2010

Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.

Melberg A et al.

Neuromuscular Disorders : Nmd, 2010

Dynamin 2 mutations associated with human diseases impair clathrin-mediated receptor endocytosis.

Bitoun M et al.

Human Mutation, 2009

Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.

Bitoun M et al.

Annals of Neurology, 2007

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."